ǰÑÔ
¸ß֬Ѫ֢(hyperlipidemia)ÊÇÒ»ÖÖÈ«ÉíÐÔ¼²²¡£¬Í¨³£ÊÇָѪÖÐ×ܵ¨¹Ì´¼ºÍ£¨»ò£©¸ÊÓÍÈýº¨¹ý¸ß¡£Ñ¡ÔñºÏÊʵ͝ÎïÄ£×ÓÊÇÑо¿¸ß֬Ѫ֢µÄÒªº¦¡£Ò»Ñùƽ³£¶øÑÔ£¬Ñ¡Óøß֬Ѫ֢ģ×ӵ͝ÎӦ¸ÃÔÚѪ½¬Ö¬ÂѰ××é³É¡¢¸ÎÔ൨¹Ì´¼¼°Ö¬ÂѰ״úлµÈ·½Ã棬ÓëÈËÀà´úÐ»ÌØÕ÷¼«ÎªÏà½ü¡£ÏêϸÌåÏÖΪ£ºµÚÒ»£¬×ܵ¨¹Ì´¼ºÏ³ÉجÖÐÓɸÎÔàºÏ³ÉµÄÁ¿Ô½Ð¡Ô½ºÃ£»µÚ¶þ£¬ÔöÌíÒûʳÖе¨¹Ì´¼º¬Á¿²»»áÒýÆðµ¨ÖËáºÏ³ÉÔöÌí¡¢²»À©³äµ¨¹Ì´¼´úл³Ø¡¢²»ÒÖÖÆµÍÃܶÈÖ¬ÂѰ×ÊÜÌå»îÐÔ¡¢²»ÍêÈ«ÒÖÖÆ¸Îµ¨¹Ì´¼µÄºÏ³É£»µÚÈý£¬¸ßÖ¬Òûʳ¿ÉÒÔÓÕµ¼¸ß¸ÊÓÍÈýº¨ÑªÖ¢¡£
ÓÉÓÚСÊóµÄ»ùÒòÐÞÊÎÊÖÒÕÒѾ³ÉÊ죬»ùÓÚ»ùÒòÐÞÊζ¯ÎïÄ£×ÓÔÚ¼²²¡Ñо¿ÖеÄÓÅÊÆ£¬¸ßµ¨¹Ì´¼ÑªÖ¢»ùÒòÐÞÊÎСÊóµÄÆÕ±éÓ¦Ó㬴ó´óÍÆ½øÁË´úлÐÔÐÄѪ¹Ü²¡µÄ¿ÆÑ§Ï£Íû¡£È»¶ø£¬Ð¡ÊóºÍÈËÀàÔÚÖ¬´úл·½ÃæÓÐÖØ´óµÄ²î±ð£¬ÀýÈçѪ½¬Ö¬ÂÑ°×Æ×²î±ð¡¢¶ÔʳÎï·´Ó¦ÐÔ²î±ð¡¢´úлø±í´ï²î±ð¡¢¸ÊÓÍÈýº¨´úл²î±ð¶Ô½µÖ¬Ò©·´Ó¦²î±ðµÈ¡£Ëæ×ÅÑо¿µÄÉîÈëºÍÀ©Õ¹£¬¼±ÐèѰÕÒ¿ª·¢ÓëÈËÀàÖ¬´úл¸üΪ¿¿½üµÄ¶¯Îï¡£´Ó³É ±¾¡¢×ÌÉúËÙÂÊ¡¢ÊµÑé²Ù×÷¡¢ÓëÈËÀàÏàËÆÐÔ¡¢»ùÒòÐÞÊÎÊÖÒÕ¡¢Â×ÀíѧµÈ·½Ãæ×ÛºÏÆÊÎö£¬½ð»ÆµØÊó¡¢¼ÒÍá¢Ð¡ÐÍÖíÊÇÊÊÊÊÓÃÓÚ¸ß֬Ѫ֢¼°Æä²¢·¢Ö¢Ñо¿µÄ¶¯Îï¡£±í5-1×ܽáÁ˼¸ÖÖ³£ÓÃʵÑ鶯ÎïµÄÖ¬´úл¼°´úлÐÔÐÄѪ¹Ü²¡µÄÌØµã¡£
²¿·ÖÔìÄ£ÒªÁì
ʹÓö¯ÎСÊó¡¢¼ÒÍá¢Ð¡ÐÍÖí
¡¾ÔìÄ£»úÖÆ¡¿£º
¸ß֬Ѫ֢ÒѾÊDZ»ÆÕ±éÈÏÖªµÄ¼²²¡Ö®Ò»£¬ÓÉÓÚÖ¬ÖÊÔÚѪ½¬ÖÐÊÇÒÔÖ¬ÂѰ׵ÄÐÎʽ±£´æ£¬Òò´Ë¸ß֬Ѫ֢ÏÖʵÉÏÊÇijÖÖ¸ßÖ¬ÂѰ×Ѫ֢¡£Ö¬ÖʵĴúлҲÊÇÒÔÖ¬ÂѰ׵ÄÐÎʽΪÖ÷£¬ÌØÊâÊÇÖ¬ÂѰ׶ÔÖ¬ÖÊתÔËËùÆðµÄ×÷Óã¬ÔÚ´úлÖÐÊÎÑÝÁËÖ÷Òª½ÇÉ«¡£
ͼ5-2×ܽáÁËÈËÀà»ù±¾µÄÖ¬ÂѰ×תÔ˺ʹúлÀú³Ì£¬ÈéÃÓ΢Á£(chylomicron,CM)¡¢VLDL¡¢LDL¡¢HDLÒÔ¼°ÈéÃÓ΢Á£²ÐÌå(CM remnants)ºÍ¼«µÍÃܶÈÖ¬ÂѰײÐÌå(VLDL remnants)ÓÐ×ÅÖØ´óµÄת»¯¡¢×ªÔËÀú³Ì£¬Ðí¶àÖ÷ÒªµÄø¡¢ÊÜÌåºÍÔØÖ¬ÂѰ׵ȼÓÈëÆäÖС£µ¨¹Ì´¼ÎªÖ÷µÄÖ¬ÂѰ×Ö÷ÒªÊÇLDL,VLDLºÍHDL,¸ÊÓÍÈýõ¥ÎªÖ÷µÄÖ¬ÂѰ×Ö÷ÒªÊÇÈéÃÓ΢Á£ºÍVLDL¡£CETP½«µ¨¹Ì´¼õ¥(cholesteryl ester, CE)´ÓHDLתÔ˵½LDL¡¢VLDL¡¢IDL£¬¶øÕâЩ֬ÂѰ×ÖеĸÊÓÍÈýõ¥ÔòÏòHDLתÔË¡£LCATÔòʹÓÎÀ뵨¹Ì´¼õ¥»¯Ôö½øµ¨¹Ì´¼ÏòHDLµÄתÔË¡£
ÓëÖ¬ÂѰ״úлÏà¹ØµÄ»ùÒò£¬°üÀ¨Ã¸¡¢ÔØÖ¬ÂѰס¢×ªÔËÂѰ׵ȣ¬¹ý±í´ï»òȱÏݾͻáÌåÏÖ¸ß֬Ѫ֢¡£ÏÖÔÚ´ó´ó¶¼¶¯ÎïÄ£×Ó¶¼ÊÇÒÔɨ³ýÕÏ°ÎªÌØÕ÷µÄ¸ß֬Ѫ֢ģ×Ó£¬ÆäÖлúÖÆÉæ¼°Ö¬ÂѰ×Éãȡɨ³ýµÄÖ¬ÂѰ×ÊÜÌåÒÔ¼°ÅäÌå¡¢Ö¬ÖÊË®½âµÄøÒÔ¼°¼¤»îÎïºÍÒÖÖÆÎï¡£ÀýÈ磺LDL;¾¶Ïà¹ØµÄÔØÖ¬ÂѰ×ApoB100¡¢ApoE,LDLrºÍÒÖÖÆÎïPCSK9,LDLÎüÊÕÏà¹ØµÄNPC1L1£»HDL;¾¶Ïà¹ØµÄÔØÖ¬ÂѰ×ApoA-¢ñ¡¢ApoA-¢ò£¬ÊÜÌåSRBl¡¢SRA¡¢ABCAl£¬Ö¬ÖÊתÔËÏà¹ØµÄCETP¡¢LCATµÈ£»¸ÊÓÍÈýõ¥Í¾¾¶Ïà¹ØµÄË®½âøLPL¼°Æä¸¨ÖúÂѰ×GPIHBPl,L Fl£»ÔØÖ¬ÂѰ×ApoC-3¡¢ApoA-¢õ¡¢ApoA-¢ô¡¢ApoC-2µÈ¡£
ͼ5-2 Ö¬ÖÊ´úлʾÒâͼ
¡¾Ä£×ÓÌØµã¡¿£º
1.¸ßµ¨¹Ì´¼ÑªÖ¢Ä£×Ó ¸ßµ¨¹Ì´¼ÑªÖ¢µÄ»ùÒòÐÞÊÎÄ£×ÓÊÇÖ¬´úл¼²²¡Ä£Ê½¶¯ÎïÖÐÓ¦ÓÃ×îÆÕ±éµÄÄ£×Ó£¬Îªµ¨¹Ì´¼´úл»úÖÆ¡¢¶¯ÂöÖàÑùÓ²»¯·¢²¡»úÖÆ¡¢½µµ¨¹Ì´¼Ò©ÎïÑз¢µÈ·½ÃæµÄÑо¿×÷³öÁËÖØ´óµÄТ˳£¬°üÀ¨Ð¡Êó¡¢¼ÒÍúÍСÐÍÖíµÈ¶¯ÎïÄ£×Ó¡£
¢Å ApoE-/-СÊóºÍLDLr-/-СÊ󵨹̴¼Í¨¹ýLDLr½éµ¼Í¾¾¶±»¸ÎÔàµÈÉãÈ¡µÄ´úлÀú³Ì³ÆÎªLDLr;¾¶¡£ÆñÂÛÊÇLDLr£¬ÕÕ¾É×÷ΪÅäÌåµÄApoEµÄȱÏÝ£¬¾ù¿Éµ¼Ö¸ߵ¨¹Ì´¼ÑªÖ¢¡£ApoE-/-СÊóѪ½¬µ¨¹Ì´¼Ë®Æ½ÉÏÉý3~5±¶£¬µÖ´ï300~500mgdl×óÓÒ£¬Ñª½¬Ö¬ÂѰ×VLDLºÍLDL×é·ÖÏÔÖøÉý¸ß£¬HDL½µµÍ¡£ÓëApoE-/-СÊóÏà±È£¬LDLr-/-СÊóѪ½¬µ¨¹Ì´¼Ë®Æ½Ö»Éý¸ß2±¶£¬¼¯ÖÐÓÚLDL×é·Ö¡£µ±¸øÓè¸ßÖ¬Òûʳ£¬LDLr-/-СÊóѪ½¬µ¨¹Ì´¼ÄÜѸËÙÉÏÉý£¬Í¨¹ý¸ßÖ¬ÒûʳÅä·½µÄµ÷½â£¬¿ÉÒÔÈËΪµØµ÷½âѪ½¬µ¨¹Ì´¼Ë®Æ½Éý¸ß5~10±¶¡£º£ÄÚ¶à¼Òµ¥Î»ÏÖÔÚÒÑÖÆ±¸³öÕâÁ½ÖÖ»ùÒòÇóý´óÊó¡£
¢Æ ApoB-100ת»ùÒòСÊó£ºÈËApoB-100ת»ùÒòСÊóLDLˮƽÏÔÖøÉý¸ß£¬Ñª½¬×ܵ¨¹Ì´¼Ë®Æ½Éý¸ß2±¶£¬¸ÊÓÍÈýõ¥Ë®Æ½Ò²ÉÔÓÐÉý¸ß¡£LDLºÍ¸ÊÓÍÈýõ¥±ÈÀýÔö¸ßºÜÊÇÏÔÖøÊǸÃÄ£×ÓµÄÌØµã¡£
¢Ç PCSK9ת»ùÒòСÊó£ºPCSK9ÒÖÖÆ¼ÁµÄ¿ª·¢ÒѾ½øÈëÁÙ´²ÊµÑ飬½«³ÉÎªÌæ»»×¨Àû±£»¤ÆÚ¼´½«µ½ÆÚµÄËûÍ¡ÀàÒ©ÎïµÄÐÂÒ©¡£PCSK9µ÷¿ØLDLr·Òëºóˮƽ½µ½â£¬ÒÖÖÆLDLrÖØ¸´Ê¹Ó㬵±¹ý±í´ïPCSK9ʱ£¬LDLr±í´ïϽµ£¬ÌåÏÖºÍLDLrÇóýÀàËÆµÄ±íÐÍ£¬¸ÃÄ£×ÓÏÖʵÉÏÏ൱ÓÚLDLr-/-СÊó¡£
¢È ApoBת»ùÒòÍ㺹ý±í´ïÈëApoB-100ת»ùÒòÍ㬲»±í´ïApoB-48£¬Ñª½¬Öе¨¹Ì´¼ºÍ¸ÊÓÍÈýõ¥µÄº¬Á¿Îª±ÈÕÕ×éµÄ2~3±¶£¬HDLµ¨¹Ì´¼ÔòÏÔÖø½µµÍ¡£Ôö¸ßµÄµ¨¹Ì´¼ºÍ¸ÊÓÍÈýõ¥Ö÷ҪΪLDL×é·Ö¡£
¢É PCSK9ת»ùÒòСÐÍÖí£º¹ý±í´ïÈ˹¦Ð§ÔöÇ¿ÐÍÍ»±äÌåD374Y-PCSK9µÄСÐÍÖí£¬ÆÕËÇÌõ¼þÏÂÌåÏÖÇá¶ÈµÄ¸ßµ¨¹Ì´¼ÑªÖ¢¡£¶ø¸øÓè¸ßÖ¬ÒûʳÓÕµ¼£¬ÏñСÊóÄ£×ÓÒ»Ñù£¬ÌåÏÖÑÏÖØµÄ¸ßµ¨¹Ì´¼ÑªÖ¢£¬¿ÉÒÔ±ÈÒ°ÉúÐͱÈÕÕ×é¸ß5±¶ÒÔÉÏ£¬ËäÈ»±ÈÕÕ×éÒ²Óиߵ¨¹Ì´¼ÑªÖ¢¡£ÌØÊâÖµµÃ×¢ÖØµÄÊÇ£¬Õâ¸öÄ£×Ó±¬·¢¹Ú×´¶¯ÂöµÄÖàÑùÓ²»¯°ß¿é£¬ÕâÔÚСÊóÄ£×ÓÉÏÊÇÊӲ첻µ½µÄ¡£
2.¸ß¸ÊÓÍÈýõ¥ÑªÖ¢Ä£×Ó
¢Å ApoC-¢óת»ùÒòÄ£×Ó£ºApoC-¢óµÄÖ÷ÒªÐÄÀí¹¦Ð§ÊÇÒÖÖÆLPL»îÐԺ͸ÎÔàÖ¬ÂѰ×ÊÜÌåÉãÈ¡CM²ÐÁ£ºÍVLDL²ÐÌå¡£ApoC-¢óת»ùÒòÄ£×ÓÊÇÒѾ±¨µÀµÄΪÊýδ¼¸µÄ¸ß¸ÊÓÍÈýõ¥ÑªÖ¢Ä£×ÓÖ®Ò»¡£ApoC-¢óת»ùÒòСÊóѪ½¬¸ÊÓÍÈýõ¥Ë®Æ½Ëæ²î±ðµÄ½¨Ä£Õß¶ø²î±ð£¬ÓеÄÔÚ300~500mg/dl×óÓÒ£¬Óеĸߴï1000mg/dlÒÔÉÏ£¬µ¨¹Ì´¼Ë®Æ½Ëæ¸ÊÓÍÈýõ¥Ë®Æ½Ð¡·ùÔö¸ß¡£¸ÃÄ£×ÓÑõ»¯Ó¦¼¤Ë®Æ½Éý¸ßÊǽÏÍ»³öµÄÌØÕ÷£¬Æä¶Ô¶¯ÂöÖàÑùÓ²»¯Ò׸ÐÐÔÔö¸ß¡£ApoC-¢óת»ùÒò¼ÒÍúÍת»ùÒòСÐÍÖíÒ²¶¼Óɱ±¾©´óѧÐÄѪ¹ÜÑо¿Ëù±¨µÀ£¬¾ùÓи߸ÊÓÍÈýõ¥ÑªÖ¢µÄ±íÐÍ£¬È»¶øÉý¸ß·ù¶È²»´ó£¬ÊÇ·Çת»ùÒò¶¯ÎïµÄ2~3±¶¡£ApoC-¢óת»ùÒò¶¯ÎïµÄѪ½¬Ö¬ÂѰ׾ùΪVLDL×é·ÖÔö¶à£¬HDL½µµÍ¡£
¢Æ ApoC-¢òת»ùÒòСÊó£ºApoC-¢òµÄ×÷ÓÃÊǼ¤»îLPL»îÐÔ£¬È»¶øApoC-¢òת»ùÒòСÊóÈ´Óи߸ÊÓÍÈýõ¥ÑªÖ¢µÄ±íÐÍ¡£¹ý±í´ïÈËApoC-¢ò»ùÒòºó£¬Ð¡ÊóµÄ½ûʳѪ½¬¸ÊÓÍÈýõ¥Ë®Æ½Éý¸ß4±¶£¬²Íºó¸ÊÓÍÈýõ¥Ë®Æ½Éý¸ß7±¶¡£¿ÉÊÇÏÖÔÚ»¹Ã»ÓиÃÄ£×ÓÓ¦Óõı¨µÀ£¬Ò²Ã»ÓÐÇóýСÊóÓ¦Óõı¨µÀ¡£ApoC-¢ñת»ùÒòСÊóÒ²±»±¨µÀÓÐÑÏÖØ¸ß¸ÊÓÍÈýõ¥ÑªÖ¢¡£
¢Ç LPL»ùÒòÇóý(LPL-/-)СÊó£ºLPLÊÇѪ½¬¸ÊÓÍÈýõ¥½µ½âµÄÏÞËÙø£¬¸Ã»ùÒòÇóýµ¼ÖÂÐÂÉúСÊóÖÂËÀ£¬Ôµ¹ÊÔÓÉ¿ÉÄܺ͵ÍѪÌǼ°·Î¹¦Ð§²»È«Óйء£±±¾©´óѧÐÄѪ¹ÜÑо¿Ëùͨ¹ýÈËLPLÓÐÒæÍ»±äÌåÏÙ²¡¶¾¶ÔÐÂÉúСÊó¾ÙÐоÈÖΣ¬»ñµÃÁËÑÏÖØ¸ß¸ÊÓÍÈýõ¥ÑªÖ¢±íÐ͵ÄLPL-/-СÊ󡣸ÃÄ£×ÓΪÑÏÖØµÄÈéÃÓ΢Á£ÑªÖ¢£¬Ñª½¬³ÊÅ£ÄÌÑùÍâ¹Û¡£ÔÚÕâ¸öÄ£×ÓÉÏÊ״δÓʵÑé½Ç¶È֤ʵÁ˸ÊÓÍÈýõ¥ºÍ¶¯ÂöÖàÑùÓ²»¯µÄ¹ØÏµ¡£Õâ¸öÄ£×ÓÉÐÓÐÔö¸ßµÄ¼±ÐÔÒÈÏÙÑ×Ò׸ÐÐԺͷºÆð×Ô¾õÐÔÒÈÏÙÑס£ApoEºÍLPLË«ÇÃСÊóÄ£×ÓÊÇÒ»¸ö»ìÏýÐ͸ß֬Ѫ֢ģ×Ó¡£
¢È GPIHBPl»ùÒòÇóý( GPIHBP1-/-£©Ð¡Êó£ºGPIHBP1ÊÇÄÚÆ¤Ï¸°ûÉøÍ¸µÄÂѰף¬Ëü궨ÔÚÄÚÆ¤Ï¸°ûÉÏ£¬Á´½ÓLPLºÍÈéÃÓ΢Á££¬ÎªLPL½µ½â ÈéÃÓ΢Á£ÖеĸÊÓÍÈýõ¥Ìṩһ¸öÇÅÁº×÷Óá£GPIHBP1-/-СÊóÌåÏÖÀàËÆ LPL-/-СÊóµÄ±íÐÍ£¬ÓÐÑÏÖØÈéÃÓ΢Á£ÑªÖ¢¡£ÓëLPL-/-²î±ðµÄÊÇ£¬¸Ã»ùÒòÇóý²»¾ßÓÐÖÂËÀÐÔ£¬Ñª½¬¸ÊÓÍÈýõ¥Ë®Æ½ÔÚ8ÖÜǰ²»¿ÉµÖ´ï1000mg/dl¡£ ¸Ã»ùÒòÇóý´óÊóº£ÄÚÒ²ÒÑ»ñµÃ¡£
¢É ApoA-V»ùÒòÇóý(ApoA-V-/-£©Ð¡Êó£ºApoA-V¼ÓÈë¸ÊÓÍÈýõ¥µÄɨ³ý£¬ÔÚÈËÀàÊ¢Ðв¡Ñ§ÊÓ²ìÖÐÒѾÃ÷È·£¬ApoA-V-/-СÊó³Ê¸ß¸ÊÓÍÈýõ¥ÑªÖ¢£¬Ñª½¬¸ÊÓÍÈýõ¥Ë®Æ½Éý¸ß4±¶×óÓÒ£¬µ«Æäɨ³ý¸ÊÓÍÈýõ¥µÄ»úÖÆ»¹²»ÇåÎú¡£
±ðµÄ£¬ABCG5/8Ë«ÇóýСÊó£¬LCAT¡¢ABCA1¡¢ApoD¡¢CD36¡¢caveolin-1ÇóýСÊó£¬ApoA-¢ò¡¢SREBP1-cת»ùÒòСÊó¡¢PLA2ת»ùÒòСÐÍÖíÒ²¶¼ÌåÏÖÇá¶ÈµÄ¸ß¸ÊÓÍÈýõ¥ÑªÖ¢£¬´ó¶à°éÓÐÒȵºËضԿ¹¡£
¡¾Ä£×ÓȪԴ¡¿£º
´ó´ó¶¼Ð¡ÊóÄ£×Ó¿ÉÒÔ´ÓÃÀ¹úJacksonʵÑéÊÒ(http://www.jax.org/index.html)¡¢MMRRC (Mutant Mouse Regional Resource Cenlers,http:// www.mmrrc.org)ºÍ¹ú¼ÒÒÅ´«¹¤³ÌСÊó×ÊÔ´¿â(http: //www.nrcmm.cn/mice/index.asp)»ñµÃ¡£´ó´ó¶¼¼ÒÍÃÄ£×Ó¿ÉÒÔ´ÓÈÕ±¾É½Àæ´óѧ»ñµÃ¡£¸ß¸ÊÓÍÈýõ¥ÑªÖ¢¶¯ÎïÄ£×Ó¿ÉÒÔ´Ó±±¾©´óѧÐÄѪ¹ÜÑо¿Ëù»ñµÃ¡£
¡¾Ä£×ÓÆÀ¹ÀºÍÓ¦Óá¿£º
¸ß¸ÊÓÍÈýõ¥ÑªÖ¢µÄ²¡ÀíÐÄÀí±È¸ßµ¨¹Ì´¼ÑªÖ¢Öش󣬸»º¬¸ÊÓÍÈýõ¥Ö¬ÂѰױÈLDLµÄÉúÎïѧЧӦÈõ£¬»ùÒòÐÞÊÎÄ£×ÓÒªÌåÏÖÑÏÖØµÄ¸ß¸ÊÓÍÈýõ¥ÑªÖ¢²ÅÓÐÓ¦ÓüÛÖµ¡£ÓÉÓÚÁÙ´²¶Ô¸ß¸ÊÓÍÈýõ¥ÑªÖ¢²»Èç¸ßµ¨¹Ì´¼ÑªÖ¢ÖØÊÓ£¬¸ß¸ÊÓÍÈýõ¥ÑªÖ¢Ä£×Ó·ºÆðÒ²½ÏÍí£¬Òò´Ë¸ß¸ÊÓÍÈýõ¥ÑªÖ¢ºÍÐÄѪ¹Ü¼²²¡¹ØÏµÖÁ½ñ²»ÊǺÜÇåÎú£¬²¢ÇÒҲûÓÐÏñËûÍ¡ÕâÑùµÄÌØÐ§Ò©¡£È»¶ø£¬ÓëÎ÷·½¹ú¼Ò²î±ð£¬ÎÒ¹úÊÇÒ»¸ö¸ß¸ÊÓÍÈýõ¥ÑªÖ¢´ó¹ú£¬¾Ýǰ¼¸ÄêÎÀÉú²¿Ðû²¼µÄͳ¼Æ×ÊÁÏÏÔʾÆäʱÎÒ¹ú¸ß¸ÊÓÍÈýõ¥ÑªÖ¢»¼ÕßÒѾµÖ´ï1Òڶ࣬´ó´óÁè¼Ý¸ßµ¨¹Ì´¼ÑªÖ¢»¼Õß¡£Òò´Ë£¬Î´À´´úлÐÔÐÄѪ¹Ü¼²²¡µÄÑо¿½«½øÈë¸ÊÓÍÈýõ¥µÄÎę̀£¬¸ß¸ÊÓÍÈýõ¥ÑªÖ¢µÄģʽ¶¯ÎォʩչÖ÷Òª×÷Óá£
ÏÖÔÚ£¬»ùÒòÐÞÊÎСÊóÔÚ¸ß֬Ѫ֢Ñо¿ÖÐÓ¦ÓÃ·Ç ³£ÆÕ±é£¬ApoE-/-ºÍLDLr-/-СÊóÏÕЩ³ÉΪÑо¿¸ß֬Ѫ֢µÈÐÄѪ¹ÜÏà¹Ø´úл¼²²¡µÄ¹¤¾ßСÊó£¬ÊÇ»ùÒòÐÞÊζ¯ÎïÄ£×ÓÖÐʹÓÃ×î¶àµÄÄ£×Ó¡£µ«ÓÉÓÚСÊóµÄÖ¬´úлºÍÈËÀà²î±ð´ó£¬¹ÊÔÚÑо¿ÖоÖÏÞÐԺܴó¡£Ëæ×Å»ùÒòÐÞÊÎÊÖÒÕµÄÉú³¤£¬¼ÒÍúÍСÐÍÖíÒѾ±¨µÀÁ˶àÖÖÖ¬´úлģʽ¶¯ÎÓÉÓÚËüÃÇÔÚÖ¬´úл·½ÃæºÍÈËÀàÔ½·¢¿¿½ü£¬ÒÔÊÇÔÚ»úÖÆÑо¿ºÍÐÂÒ©¿ª·¢·½Ã棬±ÈСÊó¸üÓÐÓ¦ÓüÛÖµ¡£Í¼5-3×ܽáÁËÓ¦ÓÃÓÚÖ¬´úл¶¯ÎïÄ£×ÓµÄѪ½¬Ö¬ÖÊÆ×£¬ÓëÈËÀàѪ½¬Ö¬ÖÊÆ×Ïà±È£¬¿ÉÒÔ·¢Ã÷×ÔÈ»ºÍÈËÀàÖ¬ÂѰ××é³ÉÀàËÆµÄ¶¯ÎïÓеØÊó¡¢È®¡¢Ð¡ÐÍÖí¡¢·ÇÈËÁ鳤Àà¡£ÕâЩ¶¯ÎïÖ¬´úÐ»ÌØµãºÍģʽ¿¿½üÈËÀ࣬×÷Ϊ֬´úлÑо¿µÄģʽ¶¯ÎïºÜÊǺÏÊÊ£¬µ«ËÇÑøÖÎÀí²»Ò×£¬Óöȹý¸ß¡£
ͼ5-3 ÖÖÖÖ¶¯ÎïѪ½¬Ö¬ÂÑ°×Æ×¿ìËÙÒºÏàÉ«Æ×(FPLC)ÆÊÎö
²Î¿¼ÎÄÏ×£º
1.Áõ¶÷᪣¬·¶½ÁØ£®×ª»ùÒòÍÃÔÚ¶¯ÂöÖàÑùÓ²»¯Ñо¿ÖеÄÓ¦Óü°Ï£Íû£®Öйú¶¯ÂöÓ²»¯ÔÓÖ¾£¬2003,11(4): 371-375
2.Al-Mashhadi RH,Sørensen CB,Kragh PM,et al.Familial hypercholesterolemia and atherosclerosis in cloned minipigs created by DNA transposition of a human PCSK9 gainof-function mutant. Sci Transl Med,2013,5 (166): 166ral
3.Ding Y, Wang Y, Zhu H, et al. Hypertriglyceridemia and delayed clearance of fat load in transgenic rabbits expressing human apolipoprotein CID. Transgenic Res, 2011,20(4):867-875
4.Gao S, He L,Ding Y,el al. Mechanisms underlying different responses of plasma triglyceride to high-fat diels in hamsters and mice: roles of hepatic MTP and triglyceridesecretion. Biochem Biophys Res Commun,2010,398(4): 619-626
5.Getz GS,Reardon CA. Animal models of atherosclerosis.Arterioscler Thromb Vasc Biol, 2012, 32 (5):1104-1115
6.Stylianou IM, Bauer RC, Reilly MP, el al. Genetic basis of atherosclerosis:insights from mice and humans. Circ Res, 2012, 110(2):337-355
7.Wei J,Ouyang H, Wang Y,el al. Characterization of a hypertriglyceridemic transgenic miniature pig model expressing human apolipoprotein CIII. FEBS J,2012,279 (1):91-99
8.Yin W, Carballo-Jane E, McLaren DG, et al. Plasma lipid profiling across species for the identification of optimal animal models of human dysl.ipidemia. J Lipid Res,2012, 53 (1):51-65
9.Zhang X, Qi R, Xian X, el al. Spontaneous atherosclerosclerosis in aged lipoprotein lipase-deficient mice with severe hypertriglyceridemia on a normal chow diet. Circ Res,2008,102 (2):250-256